RPMI 2650人鼻腔上皮細(xì)
具體成交價(jià)以合同協(xié)議為準(zhǔn)
- 公司名稱(chēng) 上海富雨生物科技有限公司
- 品牌
- 型號(hào)
- 產(chǎn)地
- 廠(chǎng)商性質(zhì) 生產(chǎn)廠(chǎng)家
- 更新時(shí)間 2025/2/11 15:05:53
- 訪(fǎng)問(wèn)次數(shù) 36
聯(lián)系方式：陳壽彬18956075901 查看聯(lián)系方式
聯(lián)系我們時(shí)請(qǐng)說(shuō)明是化工儀器網(wǎng)上看到的信息，謝謝!
人鼻腔上皮細(xì)胞 RPMI 2650
| 種屬 | 人 |
| 別稱(chēng) | RPMI 2650;RPMI2650;Roswell Park Memorial Institute 2650 |
| 組織來(lái)源 | 鼻中隔；來(lái)源于轉(zhuǎn)移部位的鱗狀細(xì)胞癌：胸腔積液 |
| 疾病 | 鱗狀細(xì)胞癌 |
| 傳代比例/細(xì)胞消化 | 1:2-1:3傳代,，消化3-5分鐘 |
| 培養(yǎng)基配置 | MEM培養(yǎng)基,；10%胎牛血清,；1%雙抗 |
| 簡(jiǎn)介 | 來(lái)自胸腔積液的一種廣泛的鼻中隔惡性腫瘤，診斷為間變性鱗狀細(xì)胞癌,。幾乎正常的核型,，穩(wěn)定的染色體數(shù)目和可能 來(lái)源于惡性細(xì)胞使細(xì)胞系的人類(lèi)細(xì)胞系。細(xì)胞非常小,，成簇生長(zhǎng),，融合形成厚層 |
| 形態(tài) | 上皮細(xì)胞樣 |
| 生長(zhǎng)特征 | 貼壁生長(zhǎng) |
| 倍增時(shí)間 | ~40-50h |
| 基因表達(dá) | mucoid:keratin |
| STR | Amelogenin:X,Y CSF1P0:9,11 D13S317:11,12 D16S539:11,12 D5S818:12,13 D7S820:8,11 THO1:6,8 TPOX:8yWA:16.18 |
| 保藏機(jī)構(gòu) | ATCC;CCL-30 |
immunotherapy.Oncology nurses have worked within the three pillars of cancer care-surgery, chemotherapy, and radiation therapy -for decades. Now, immuno-oncologic (I-O) therapy agents are a new paradigm in cancer treatment. On March 28, 2017, an I-O think tank was held at the Oncology Nursing Society (ONS) in Pittsburgh, PA. This think tank was organized in response to the rapid changes in cancer treatment with the advent of I-O therapies. The think tank appraised
采購(gòu)中心
化工儀器網(wǎng)